Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00120913 · ClinicalTrials.gov registry record · NA
Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given?
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT00120913 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 160 participants.
The verdict
NCT00120913, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
While there may be a decrease in the total number of bleeding days women experience with continuous-dosed COCs (no menstrual withdrawal week), these regimens frequently result in an increased number of "breakthrough" or non-scheduled bleeding days. Breakthrough bleeding is among the main reasons cited for discontinuation of combined COCs dosed traditionally (3 weeks of active pill, 1 week of placebo) or continuously, and may offset the perceived benefit of fewer withdrawal bleeding events for many women taking continuous-dosed COCs. The exact mechanisms responsible for breakthrough bleeding patterns during hormonal contraception are unknown and may be related to the pill formulation. This study is to determine whether progestin type or estrogen dose influences bleeding patterns, side effects, or satisfaction with combined oral contraceptives (COC) dosed continuously.
Interventions
- DRUG Birth control pills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Est. Completion | 2004-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00120913
The ClinicalTrials.gov registry entry for NCT00120913 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Birth control pills is the first listed.
NCT00120913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00120913 about?
NCT00120913 is a clinical study titled "Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given?". While there may be a decrease in the total number of bleeding days women experience with continuous-dosed COCs (no menstrual withdrawal week), these regimens frequently result in an increased number of "breakthrough" or non-scheduled bleeding days. Breakthrough bleeding is among the main reasons cit...
What is the current status of trial NCT00120913?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. Estimated completion is 2004-08.
What interventions are being tested in trial NCT00120913?
The interventions under investigation include: Birth control pills (DRUG).
Who is sponsoring clinical trial NCT00120913?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.